InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Lund- Jürgensen Kirsten, Dirigeant. Officer active across 1 companies, notably UCB. In total, 7 disclosures have been published. The latest transaction was disclosed on 10 April 2026 (Sale). Regulator: FSMA. The full history is accessible without signup.
Declarations7 total
€835,4253,084 shares@ €270.890.0019% mcap22.3% of flow
ShareEuronext Brussels
FSMA:ucb-126·
02,549 shares0
Options /warrants for employees or managersOff exchange
FSMA:ucb-18·
Ideal exit: 27 Dec 2026 (T+270)
03,084 shares0
ShareOff exchange
FSMA:ucb-225·
Ideal exit: 27 Dec 2026 (T+270)
€1m3,660 shares@ €287.290.0023% mcap28.1% of flow
ShareEuronext Brussels
FSMA:ucb-125·
€1,0393,615 shares@ €287.290.0000% mcap0.0% of flow
ShareEuronext Brussels
FSMA:ucb-9·
€1m3,682 shares@ €287.290.0023% mcap28.2% of flow
ShareEuronext Brussels
FSMA:ucb-181·
€801,2805,746 shares@ €139.450.0018% mcap21.4% of flow
OtherOff exchange
FSMA:ucb-31·
7 of 7 declarations
About Lund- Jürgensen Kirsten
Kirsten Lund-Jürgensen is a senior executive at UCB, a biopharmaceutical company. She is responsible for managing operations and product innovation. Her expertise contributes to the growth and reputation of UCB in the market.
